About
Centinel Spine Holdco, Inc.
Centinel Spine is a commercial-stage medical technology company with a singular mission to transform spine surgery by advancing motion-preserving solutions for the cervical and lumbar spine.
We are exclusively focused on Total Disc Replacement (TDR), which we believe represents a fundamentally different and increasingly important approach to spine surgery compared to traditional fusion techniques that permanently eliminate motion.
Our prodisc platform is designed to improve the long-term quality of life for patients suffering from chronic neck and back pain while preserving the spine’s natural movement.
Centinel Spine Holdco, Inc. Overview
Ticker, listing venue and issuer profile
Offer & Key Dates
Pricing terms and IPO milestones
Financial Highlights
Historical financial performance
SEC Filings
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| S-1 | Oct 7, 2026 | General form for registration of securities under the Securities Act of 1933 |
| DRS/A | Aug 3, 2026 | [Amend] [Cover] Draft Registration Statement |
| DRS/A | Jun 29, 2026 | [Amend] [Cover] Draft Registration Statement |
| DRS | May 8, 2026 | [Cover] Draft Registration Statement |
Company Info
Contact and headquarters details
Leadership
Key executives and officers
Steven Murray
Chief Executive Officer
Varun Gandhi
Chief Financial Officer
Jeanina Bradley
VP, U.S. Sales
Fadel Ghossein
VP, International
Jason Hoffman
VP, Business and Market Development
James Kuras
VP, Clinical, Regulatory and Quality Affairs
Vincent Lesniewski
VP, Medical Education and Clinical Accounts
Peter Ringwood
VP, Operations
Steven Sanderson
VP, Marketing and Product Development
Ali Abdullah Al Amri
Director
